Inhibitor,Target,MW,Formula,InChI,PubChem_CID,SMILES,Synonymns
GSK650394A,SGK1,382.5,C25H22N2O2,"InChI=1S/C25H22N2O2/c28-25(29)20-11-10-18(12-21(20)17-8-4-5-9-17)23-15-27-24-22(23)13-19(14-26-24)16-6-2-1-3-7-16/h1-3,6-7,10-15,17H,4-5,8-9H2,(H,26,27)(H,28,29)",25022668,C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O,"GSK 650394|890842-28-1|GSK650394|GSK-650394|UNII-56887611DJ|2-cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid|CHEMBL558642|AK170277|56887611DJ|2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoic acid|MLS006010262|SCHEMBL3767908|GTPL8040|CHEBI:95066|KS-00000SYH|CTK8F0693|SYN5178|DTXSID60237532|AOB4299|HMS3743K03|HMS3677P22|HMS3653A19|HMS3413P22|HMS2043A20|EX-A2233|BCP08392|MFCD12828779|ZINC43015507|BDBM50296011|2441AH|s7209|AKOS024457693|Benzoic acid, 2-cyclopentyl-4-(5-phenyl-"
SGK-Sanofi-14i,SGK1,430.87,C18H15ClN6O3S,,,,SHN-2122
SGK1-Sanofi-14g,SGK1,435.29,C17H12Cl2N6O2S,,,,SHN-2121
SGK1-Sanofi-14h,SGK1,435.29,C17H12Cl2N6O2S,,,,SHN-2217
SGK1-Sanofi-14n,SGK1,418.83,C17H12CIFN6O2S,,,,SHN-2108
Bay 65-1942,IKBKB,431.91,C22H26ClN3O4,"InChI=1S/C22H25N3O4.ClH/c26-18-4-1-5-19(28-11-13-6-7-13)20(18)17-9-15(14-3-2-8-23-10-14)16-12-29-22(27)25-21(16)24-17;/h1,4-5,9,13-14,23-24H,2-3,6-8,10-12H2,(H,25,27);1H/b20-17-;/t14-;/m1./s1",66575052,C1CC(CNC1)C2=CC(=C3C(=O)C=CC=C3OCC4CC4)NC5=C2COC(=O)N5.Cl,SHN-744| Bay 65-1942 HCl salt| CS-0623| HY-50948| Bay651942
BMS345541 (IKK Inhibitor III),IKBKB,291.78,C14H18ClN5,"InChI=1S/C14H17N5.ClH/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15;/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18);1H",9926054,CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN.Cl,"547757-23-3|BMS-345541|BMS 345541|UNII-BXU277OCN5|BMS-345541 hydrochloride|BXU277OCN5|CHEMBL471496|BMS-345541 HCl|BMS-345541 (hydrochloride)|N-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride|N1-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine hydrochloride|MLS006010273|C14H17N5.ClH|SCHEMBL14141907|DTXSID70203243|BCP06515|AOB33720|MFCD07784499|3498AH|AKOS025142023|SB19542|SMR004701344|HY-10518|FT-0707919|EC-000.2121|BMS-345541, &gt;=98% (HPLC), powder|W-5360|1,2-Ethan"
MLN120B,IKBKB,439.72,C19H17Cl3N4O2,,,,SHN-885| MLN 120B| MLN-120B
BX-320,PDPK1,547.4,C23H31BrN8O3,"InChI=1S/C23H31BrN8O3/c1-23(2,19(25)33)20(34)27-10-6-9-26-18-17(24)14-28-21(31-18)29-15-7-5-8-16(13-15)30-22(35)32-11-3-4-12-32/h5,7-8,13-14H,3-4,6,9-12H2,1-2H3,(H2,25,33)(H,27,34)(H,30,35)(H2,26,28,29,31)",657138,CC(C)(C(=O)N)C(=O)NCCCNC1=NC(=NC=C1Br)NC2=CC(=CC=C2)NC(=O)N3CCCC3,"BX-320|702676-93-5|UNII-B504GXS5SM|BX320|B504GXS5SM|LI8|N-(3-{[5-bromo-2-({3-[(pyrrolidin-1-ylcarbonyl)amino]phenyl}amino)pyrimidin-4-yl]amino}propyl)-2,2-dimethylpropanediamide|N-(3-{[5-BROMO-2-({3-[(PYRROLIDIN-1-YLCARBONYL)AMINO]PHENYL}AMINO)PYRIMIDIN-4-YL]AMINO}PROPYL)-2,2-DIMETHYLMALONAMIDE|1z5m|AC1LCW3A|SCHEMBL3871286|CHEMBL573108|BDBM17053|DTXSID80220507|ZINC3986667|EN002623|N-(3-(4-(3-(3-amino-2,2-dimethyl-3-oxopropanamido)propylamino)-5-bromopyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide|Propa"
BX-517,PDPK1,282.3,C15H14N4O2,"InChI=1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8-",11161844,CC(=C1C2=C(C=CC(=C2)NC(=O)N)NC1=O)C3=CC=CN3,"BX517|BX-517|850717-64-5|UNII-SYV8VN8W5K|SYV8VN8W5K|BX517(PDK1 inhibitor2)|Urea, (2,3-dihydro-2-oxo-3-(1-(1H-pyrrol-2-yl)ethylidene)-1H-indol-5-yl)-|pdk-1 inhibitors|Urea, [2,3-dihydro-2-oxo-3-[1-(1H-pyrrol-2-yl)ethylidene]-1H-indol-5-yl]-|PDK1 inhibitor 2|Indolinone based inhibitor, 4i|SCHEMBL5567818|CHEMBL228654|5-Ureido-3-(1-(pyrrol-2-yl)ethylidene)indolin-2-one|BDBM17004|BCP16225|EX-A2243|ZINC14962724|CS-6066|Urea, N-(2,3-dihydro-2-oxo-3-((3Z)-1-(1H-pyrrol-2-yl)ethylidene)-1H-indol-5-yl)-|Urea, N-(2,3-d"
BX-517 Analog (compound 7b),PDPK1,345.4,C19H15N5O2,"InChI=1S/C19H15N5O2/c20-19(26)23-13-3-4-17-15(7-13)16(18(25)24-17)8-14-6-12(10-22-14)11-2-1-5-21-9-11/h1-10,22H,(H,24,25)(H3,20,23,26)/b16-8-",11588244,c1cc(cnc1)c2cc([nH]c2)/C=C\3/c4cc(ccc4NC3=O)NC(=O)N,"Indolinone based compound, 7b|SCHEMBL3470757|CHEMBL375236|BDBM16993|[(3Z)-2-oxo-3-{[4-(pyridin-3-yl)-1H-pyrrol-2-yl]methylidene}-2,3-dihydro-1H-indol-5-yl]urea"
BX-795,PDPK1,591.5,C23H26IN7O2S,"InChI=1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30)",10077147,C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I,BX795|702675-74-9|BX-795|BX 795|N-[3-[[5-IODO-4-[[3-[(2-THIENYLCARBONYL)AMINO]PROPYL]AMINO]-2-PYRIMIDINYL]AMINO]PHENYL]-1-PYRROLIDINECARBOXAMIDE|N-(3-{[5-Iodo-4-({3-[(Thiophen-2-Ylcarbonyl)amino]propyl}amino)pyrimidin-2-Yl]amino}phenyl)pyrrolidine-1-Carboxamide|N-(3-(5-iodo-4-(3-(thiophene-2-carboxamido)propylamino)pyrimidin-2-ylamino)phenyl)pyrrolidine-1-carboxamide|C23H26IN7O2S|N-[3-[[5-iodo-4-[3-(thiophene-2-carbonylamino)propylamino]pyrimidin-2-yl]amino]phenyl]pyrrolidine-1-carboxamide|N-(3-((5-iodo-4-(
GSK2334470,PDPK1,462.6,C25H34N8O,"InChI=1S/C25H34N8O/c1-15-8-9-17(24(34)28-18-6-4-3-5-7-18)14-33(15)22-13-20(29-25(27-2)30-22)16-10-11-19-21(12-16)31-32-23(19)26/h10-13,15,17-18H,3-9,14H2,1-2H3,(H,28,34)(H3,26,31,32)(H,27,29,30)/t15-,17+/m1/s1",46215815,CC1CCC(CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5,"GSK2334470|1227911-45-6|GSK 2334470|GSK-2334470|CHEMBL1765740|(3S,6R)-1-[6-(3-Amino-1H-indazol-6-yl)-2-(methylamino)-4-pyrimidinyl]-N-cyclohexyl-6-methyl-3-piperidinecarboxamide|(3S,6R)-1-[6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl]-N-cyclohexyl-6-methylpiperidine-3-carboxamide|QLPHOXTXAKOFMU-WBVHZDCISA-N|MLS006011255|GTPL8008|SCHEMBL1317022|C25H34N8O|CHEBI:91465|DTXSID40673111|AOB6843|EX-A1544|ZINC68203217|2445AH|BDBM50341243|s7087|AKOS024458000|SB19280|QC-8425|CS-0917|HY-14981|AS-16973|SMR0"
Merck 7 (PDK1),PDPK1,516.5,C28H22F2N4O4,"InChI=1S/C29H23F2N3O4/c30-23-11-8-18(13-24(23)31)16-34-12-4-7-22(29(34)37)28(36)33-26(19-5-2-1-3-6-19)17-38-21-10-9-20-14-27(35)32-25(20)15-21/h1-13,15,26H,14,16-17H2,(H,32,35)(H,33,36)/t26-/m0/s1",,c1ccc(cc1)[C@H](COc2ccc3c(c2)NC(=O)C3)NC(=O)c4cccn(c4=O)Cc5ccc(c(c5)F)F,SHN-1424| SHN1424| SHN 1424
OSU-03012,PDPK1,460.4,C26H19F3N4O,"InChI=1S/C26H19F3N4O/c27-26(28,29)24-14-23(33(32-24)20-10-8-19(9-11-20)31-25(34)15-30)18-7-12-22-17(13-18)6-5-16-3-1-2-4-21(16)22/h1-14H,15,30H2,(H,31,34)",10027278,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
Wyeth PDK1 Inhibitor Compound 1,PDPK1,480.21,C19H22Cl4N4O2,,,,SHN-680
(5Z)-7-Oxozeaenol,MAP3K7,362.4,C19H22O7,"InChI=1S/C19H22O7/c1-11-5-3-7-14(20)18(23)15(21)8-4-6-12-9-13(25-2)10-16 (22)17(12)19(24)26-11/h3-4,6-7,9-11,15,18,21-23H,5,8H2,1-2H3",53442201,CC1CC=CC(=O)C(C(CC=CC2=CC(=CC(=C2C(=O)O1)O)OC)O)O,253863-19-3|66018-38-0
NG-25,MAP3K7,537.6,C29H30F3N5O2,"InChI=1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38)",53340664,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)OC4=C5C=CNC5=NC=C4)C(F)(F)F,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
Amgen-NIK-28,MAP4K4,332.4,C20H20N4O,"InChI=1S/C20H20N4O/c1-20(2,25)9-8-12-6-7-15-14(10-12)17-16(23-15)5-3-4-13-11-22-19(21)24-18(13)17/h6-7,10-11,23,25H,3-5H2,1-2H3,(H2,21,22,24)",,CC(C)(C#Cc1ccc2c(c1)c-3c([nH]2)CCCc4c3nc(nc4)N)O,SHN-1-864
NIK-Novartis-T1-7,MAP4K4,362.41,C18H14N6OS,"InChI=1S/C18H14N6OS/c1-18(25,16-20-8-9-26-16)6-4-12-2-3-13-14(10-12)24(11-22-13)15-5-7-21-17(19)23-15/h2-3,5,7-11,25H,1H3,(H2,19,21,23)",,CC(C#Cc1ccc2c(c1)n(cn2)c3ccnc(n3)N)(c4nccs4)O,Novartis NIK inhibitor| SHN-2235| SHN 2235| SHN2235
AG1478 (Tyrphostin),EGFR,315.75,C16H14ClN3O2,"InChI=1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)",2051,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC,"AG-1478|153436-53-4|Tyrphostin AG 1478|N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine|175178-82-2|Tyrphostin AG-1478|4-(3-Chloroanilino)-6,7-dimethoxyquinazoline|AG 1478|AG1478|AG-1478 (Tyrphostin AG-1478)|4-Quinazolinamine, N-(3-chlorophenyl)-6,7-dimethoxy-|UNII-SUH0SEZ9HY|SUH0SEZ9HY|AG-1478 hydrochloride|TYRPHOSTIN|CHEMBL7917|CHEBI:75404|N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine|NSC-693255|AK-63142|N-(3-chlorophenyl)-6,7-dimethoxy-quinazolin-4-amine|BRD6408|BRD-6408|SR-01000076156|NSC693255|t"
AG490,EGFR,294.3,C17H14N2O3,"InChI=1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+",5328779,C1=CC=C(C=C1)CNC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N,"133550-30-8|Tyrphostin B42|AG-490|Tyrphostin AG 490|AG 490|AG490|(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide|Tyrphostin AG490|tyrphostin AG-490|AG-490 (Tyrphostin B42)|alpha-Cyano-(3,4-dihydroxy)-N-benzylcinnamide|N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide|(2E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide|CHEMBL56543|134036-52-5|(E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide|(2E)-2-CYANO-3-(3,4-DIHYDROXYPHENYL)-N-(PHENYLMETHYL)-2-PROPENAMIDE|SMR001230665|SR-010000761"
"BAY439006 (Sorafenib, Nexavar)",RAF1,464.8,C21H16ClF3N4O3,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",216239,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,Sorafenib|284461-73-0|Nexavar|BAY 43-9006|4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide|UNII-9ZOQ3TZI87|4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE|N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide|CHEMBL1336|9ZOQ3TZI87|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]pheno
GW441756 hydrochloride,NTRK1,311.8,C17H14ClN3O,"InChI=1S/C17H13N3O.ClH/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16;/h2-10H,1H3,(H,19,21);1H",16219400,CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC=N4)NC3=O.Cl,"GW441756 hydrochloride|CTK8G0120|504433-24-3 (free base)|G-191|GW441756 hydrochloride, &gt;=97% (HPLC), powder, red|(3Z)-3-[(1-methylindol-3-yl)methylidene]-1H-pyrrolo[3,2-b]pyridin-2-one; hydrochloride."
Princeton's TrkA inhibitor compound 20h,NTRK1,661.52,C24H24BrF3N6O4S2,"InChI=1S/C22H23BrN6O2S2.C2HF3O2/c1-14-5-6-15(11-16(14)21(31)29-9-7-28(8-10-29)19(30)12-24)32-20-13-25-22(33-20)27-18-4-2-3-17(23)26-18;3-2(4,5)1(6)7/h2-6,11,13H,7-10,12,24H2,1H3,(H,25,26,27);(H,6,7)",,Cc1ccc(cc1C(=O)N2CCN(CC2)C(=O)CN)Sc3cnc(s3)Nc4cccc(n4)Br.C(=O)(C(F)(F)F)O,SHN-753| Trk a| Trk-a
KIN 112,LCK,568.67,C32H36N6O4,,,,SHN-1579| SHN1579| SHN 1579| KIN112| KIN112
RO-3306,CDK1,351.5,C₁₈H₁₃N₃OS₂,"InChI=1S/C18H13N3OS2/c22-17-16(24-18(21-17)20-11-14-4-2-8-23-14)10-12-5-6-15-13(9-12)3-1-7-19-15/h1-10H,11H2,(H,20,21,22)",71433937,C1=CC2=C(C=CC(=C2)C=C3C(=O)N=C(S3)NCC4=CC=CS4)N=C1,Cdk1 Inhibitor IV
PD 184352 (CI-1040),YES1,478.7,C17H14ClF2IN2O2,"InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)",6918454,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"212631-79-3|CI-1040|PD184352|PD 184352|PD-184352|2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|PD184352 (CI-1040)|CI 1040|PD 184,352|CI1040|2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide|PD-18435|2-((2-Chloro-4-iodophenyl)amino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|UNII-R3K9Y00J04|CHEMBL105442|R3K9Y00J04|MFCD02683961|NCGC00189074-01|C.I. 1040|CI-1040 (PD184352)|DSSTox_RID_83140|DSSTox_CID_28871|DSSTox_GSID_48945|C17H14ClF2IN2O2|2-(2-chloro-4-i"
Quercetagetin,PIM1,318.23,C15H10O8,"InChI=1S/C15H10O8/c16-6-2-1-5(3-7(6)17)15-14(22)13(21)10-9(23-15)4-8(18)11(19)12(10)20/h1-4,16-20,22H",5281680,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C(=C(C=C3O2)O)O)O)O)O)O,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
PD 0332991,CDK4,483.99,C24H30ClN7O2,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",5330286,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,SHN-1106| PD0332991| PD-0332991
1 NA-PP1 (PP1 Analog),SRC,317.4,C19H19N5,"InChI=1S/C19H19N5/c1-19(2,3)24-18-15(17(20)21-11-22-18)16(23-24)14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H2,20,21,22)",4877,CC(C)(C)N1C2=C(C(=N1)C3=CC=CC4=CC=CC=C43)C(=NC=N2)N,"1-NAPHTHYL PP1|221243-82-9|1-NA-PP1|pp1 analog|1-(tert-Butyl)-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|4-Amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine|1-(1,1-dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1-Na PP1|CHEMBL264406|CHEBI:52310|1-tert-butyl-3-(naphthalen-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1-tert-butyl-3-naphthalen-1-ylpyrazolo[3,4-d]pyrimidin-4-amine|1-tert-butyl-3-naphthalen-1-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine|W-201916|C19H19N5|4-Am"
1 NM-PP1 (PP1 Analog II),SRC,331.4,C20H21N5,"InChI=1S/C20H21N5/c1-20(2,3)25-19-17(18(21)22-12-23-19)16(24-25)11-14-9-6-8-13-7-4-5-10-15(13)14/h4-10,12H,11H2,1-3H3,(H2,21,22,23)",5154691,CC(C)(C)N1C2=C(C(=N1)CC3=CC=CC4=CC=CC=C43)C(=NC=N2)N,"1-NM-PP1|221244-14-0|PP1 Analog II, 1NM-PP1|1-tert-butyl-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1NM-PP1(PP1 Analog II)|NM-PP1|Mutant Kinases Inhibitor II|1 NM-PP1|PP1 ANALOG II|AC1NP9I6|4-Amino-1-tert-butyl-3-(1'-naphthylmethyl)pyrazolo[3,4-d]pyrimidine|CHEMBL573578|CHEBI:52309|1-(tert-butyl)-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|MMV676599|1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|W-201917|C20H21N5|1-tert-butyl-3-(naphth"
Bosutinib,SRC,530.4,C26H29Cl2N5O3,"InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)",5328940,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"Bosutinib|380843-75-4|SKI-606|Bosutinib (SKI-606)|SKI 606|SKI606|BOSULIF|UNII-5018V4AEZ0|4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile|4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile|CHEMBL288441|4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|CHEBI:39112|5018V4AEZ0|MFCD07367846|4-(2,4-dichloro-5-methoxyanilino)-6-me"
Dasatinib,SRC,488,C22H26ClN7O2S,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27) ",3062316,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCOCopy,"Dasatinib|302962-49-8|Sprycel|BMS-354825|BMS 354825|BMS354825|dasatinibum|Dasatinib (anhydrous)|Dasatinib (BMS-354825)|N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE|N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide|anh. dasatinib|Dasatinib [USAN]|BMS Dasatinib|UNII-X78UG0A0RN|anhydrous dasatinib|dasatinib (anh.)|N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyet"
PP1,SRC,281.36,C16H19N5,"InChI=1S/C16H19N5/c1-10-5-7-11(8-6-10)13-12-14(17)18-9-19-15(12)21(20-13)16(2,3)4/h5-9H,1-4H3,(H2,17,18,19)",1400,CC1=CC=C(C=C1)C2=NN(C3=C2C(=NC=N3)N)C(C)(C)C,"172889-26-8|PP1|PP 1|1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1-tert-butyl-3-(4-methylphenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine|CHEMBL306380|1-ter-butyl-3-p-tolyl-1h-pyrazolo[3,4-d]pyrimidin-4-ylamine|1-tert-butyl-3-p-tolyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine|AGL 1872|1H-Pyrazolo[3,4-d]pyrimidin-4-amine,1-(1,1-dimethylethyl)-3-(4-methylphenyl)-|1-tert-butyl-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine|C16H19N5|1-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN"
PP2,SRC,301.77,C15H16ClN5,"InChI=1S/C15H16ClN5/c1-15(2,3)21-14-11(13(17)18-8-19-14)12(20-21)9-4-6-10(16)7-5-9/h4-8H,1-3H3,(H2,17,18,19)",4878,CC(C)(C)N1C2=C(C(=N1)C3=CC=C(C=C3)Cl)C(=NC=N2)N,"172889-27-9|pp2|PP 2|1-(tert-butyl)-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|AG 1879|1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|InSolution&amp;trade; PP2|AGL 1879|4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine|PP 2 (AG 1879)|AG-1879|CHEMBL406845|CHEBI:78331|1-tert-butyl-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-amine|AK-60369|C15H16ClN5|1qpe|3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|4few|PBBRWFOVCUAONR-UHFFFAOYSA-N"
PP3,SRC,211.22,C11H9N5,"InChI=1S/C11H9N5/c12-10-9-6-15-16(11(9)14-7-13-10)8-4-2-1-3-5-8/h1-7H,(H2,12,13,14)",4879,C1=CC=C(C=C1)N2C3=C(C=N2)C(=NC=N3)N,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
Saracatinib (AZD0530),SRC,542,C27H32ClN5O5,"InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",10302451,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,"Saracatinib|379231-04-6|AZD0530|Saracatinib (AZD0530)|AZD-0530|AZD 0530|UNII-9KD24QGH76|N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine|SARACATINIB, FREE BASE|CHEMBL217092|9KD24QGH76|N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine|N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine|4-(6-Chloro-2,3-methylen"
SRC Inhibitor 1,SRC,373.4,C22H19N3O3,"InChI=1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25)",1474853,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC,"Src Kinase Inhibitor I|179248-59-0|Src Inhibitor 1|Src I1|Src-l1|Src I 1|Src Inhibitor-1|6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine|SKI-1|CHEMBL97771|4-Quinazolinamine, 6,7-dimethoxy-N-(4-phenoxyphenyl)-|CHEBI:78332|6,7-dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine|4-(4'-PHENOXYANILINO)-6,7-DIMETHOXYQUINAZOLINE|4-(4&amp;prime;-Phenoxyanilino)-6,7-dimethoxyquinazoline|Src-I1|Src Kinase Inhibitor 1|AC1LT1HN|Bionet1_003516|Oprea1_231056|GTPL6042|SCHEMBL1387206|KS-00002WRA|HMS578L18|CTK0E3319|AOB5689"
SU-6656,SRC,371.5,C19H21N3O3S,"InChI=1S/C19H21N3O3S/c1-22(2)26(24,25)14-7-8-18-15(11-14)16(19(23)21-18)10-13-9-12-5-3-4-6-17(12)20-13/h7-11,20H,3-6H2,1-2H3,(H,21,23)/b16-10-",5312137,CN(C)S(=O)(=O)C1=CC2=C(C=C1)NC(=O)C2=CC3=CC4=C(N3)CCCC4,"su6656|SU 6656|330161-87-0|SU-6656|InSolution&amp;trade; SU6656|CHEMBL605003|MFCD10565928|(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide|2-Oxo-3-[1-(4,5,6,7-tetrahydro-1H-indol-2-yl)-meth-(Z)-ylidene]-2,3-dihydro-1H-indole-5-sulfonic acid dimethylamide|(Z)-N,N-dimethyl-2-oxo-3-((4,5,6,7-tetrahydro-1H-indol-2-yl)methylene)indoline-5-sulfonamide|(3Z)-N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide|SR-010000"
2-Aminopurine,EIF2AK2,135.13,C5H5N5,"InChI=1S/C5H5N5/c6-5-7-1-3-4(10-5)9-2-8-3/h1-2H,(H3,6,7,8,9,10)",9955,C1=C2C(=NC(=N1)N)N=CN2,"2-aminopurine|7H-purin-2-amine|452-06-2|1H-PURIN-2-AMINE|9H-Purin-2-amine|Purine, 2-amino-|Aminopurine|SQ 22451|191236-69-8|2-amino purine|2'-amino-purine|UNII-O14B3U97FW|CCRIS 759|9H-Purin-2-ylamine|EINECS 207-197-4|NSC 24129|SQ 22,451|O14B3U97FW|CHEMBL388594|purine-2-ylamine|CHEBI:479072|MWBWWFOAEOYUST-UHFFFAOYSA-N|NSC24129|MFCD00005566|W-202796|Isoadenine|SMR000857109|3h-purin-2-amine|PubChem9263|2-Aminopurine, 98%|9H-Purin-2-amine #|BiomolKI_000044|Isoadenine Dihydrochloride|ACMC-1AD7C|BiomolKI2_000050|"
PKR Inhibitor,EIF2AK2,268.3,C13H8N4OS,"InChI=1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3-",6490494,C1=CC2=C(C3=C1NC(=O)C3=CC4=CN=CN4)SC=N2 ,"PKR Inhibitor|AC1O5VPR|ASN 11124542|RNA-Dependent Protein Kinase Inhibitor|608512-97-6|(Z)-8-((1H-Imidazol-4-yl)methylene)-6H-thiazolo[5,4-e]indol-7(8H)-one|SCHEMBL9886520|GTPL6026|CHEMBL235641|6,8-Dihydro-8-(1H-imidazol-5-ylmethylene)-7H-pyrrolo[2,3-g]benzothiazol-7-one|HMS3229I15|ZINC4908387|AKOS025147356|CCG-206776|NCGC00387501-01|RT-015072|A13538|Imidazolo-oxindole PKR inhibitor C16, &gt;=98% (HPLC)|(Z)-8-((1H-imidazol-5-yl)methylene)-6,8-dihydro-7H-thiazolo[5,4-e]indol-7-one|(8Z)-8-(1H-imidazol-5-ylmet"
PD 184352 (CI-1040),MAPK3,478.7,C17H14ClF2IN2O2,"InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)",6918454,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"212631-79-3|CI-1040|PD184352|PD 184352|PD-184352|2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|PD184352 (CI-1040)|CI 1040|PD 184,352|CI1040|2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide|PD-18435|2-((2-Chloro-4-iodophenyl)amino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|UNII-R3K9Y00J04|CHEMBL105442|R3K9Y00J04|MFCD02683961|NCGC00189074-01|C.I. 1040|CI-1040 (PD184352)|DSSTox_RID_83140|DSSTox_CID_28871|DSSTox_GSID_48945|C17H14ClF2IN2O2|2-(2-chloro-4-i"
A-443654,AKT1,397.5,C24H23N5O,"InChI=1S/C24H23N5O/c1-15-22-10-16(6-7-24(22)29-28-15)17-9-20(13-26-11-17)30-14-19(25)8-18-12-27-23-5-3-2-4-21(18)23/h2-7,9-13,19,27H,8,14,25H2,1H3,(H,28,29)/t19-/m0/s1",10172943,CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N,"A-443654|552325-16-3|A 443654|(2s)-1-(1h-Indol-3-Yl)-3-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}propan-2-Amine|(S)-1-(5-(3-Methyl-1H-indazol-5-yl)pyridin-3-yloxy)-3-(1H-indol-3-yl)propan-2-amine|5-{5-[(2S)-2-amino-3-(1H-indol-3-yl)propoxy]pyridin-3-yl}-3-methyl-1H-indazole|A443654|L20|indazole-pyridine, 4|5-indazolyl pyridine 3|a-443654 dihydrochloride|MLS002232275|SCHEMBL570604|CHEMBL379300|A-4436554|GTPL8204|BDBM15131|CHEBI:91351|DTXSID20436347|(2S)-1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)p"
Akti 1/2,AKT1,551.6,C34H29N7O,"InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)",10196499,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=CC7=C(C=C6N=C5C8=CC=CC=C8)N=CN7,Akt inhibitor VIII| Akti-1/2| Akt Inhibitor VIII| Isozyme-Selective| Akti-1/2| Imidazoquinoxaline 16h| SureCN2193282| MLS003509084
MK-2206,AKT1,480.4,C25H23Cl2N5O,"InChI=1S/C25H21N5O.2ClH/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31;;/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31);2*1H",46930998,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl,"1032350-13-2|MK-2206 dihydrochloride|MK-2206 2HCl|MK2206|MK-2206 HCl salt|UNII-Q34I3E28IO|MK 2206|MK 2206 2HCl|8-[4-(1-AMINOCYCLOBUTYL)PHENYL]-9-PHENYL-1,2,4-TRIAZOLO[3,4-F][1,6]NAPHTHYRIDIN-3(2H)-ONE DIHYDROCHLORIDE|Q34I3E28IO|8-(4-(1-Aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one dihydrochloride|AK172013|C25H21N5O|8-(4-(1-aminocyclobutyl)phenyl)-9-phenyl-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one|PubChem22473|C25H21N5O.HCl|C25H21N5O.2HCl|SCHEMBL17100521|KS-00000S"
Akti 1/2,AKT2,551.6,C34H29N7O,"InChI=1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42)",10196499,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=CC7=C(C=C6N=C5C8=CC=CC=C8)N=CN7,Akt inhibitor VIII| Akti-1/2| Akt Inhibitor VIII| Isozyme-Selective| Akti-1/2| Imidazoquinoxaline 16h| SureCN2193282| MLS003509084
SL-327 (MEK1-2 Inhibitor),MAP2K2,335.3,C16H12F3N3S,JLOXTZFYJNCPIS-FYWRMAATSA-N,9549284,C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F,SL327|305350-87-2|SL-327|SL 327|MEK1/2 Inhibitor|(Z)-3-amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile|MFCD06411432|Z-&amp; E-alpha-(Amino-((4-aminophenyl)thio)methylene)-2-(trifluoromethyl)benzeneacetonitrile|K00090|SCHEMBL570318|SCHEMBL570317|GTPL6008|CHEBI:92211|DTXSID90429549|AOB5954|alpha-[Amino-(4-aminophenylthio)methylene)-2-(trifluoromethyl)phenylacetonitrile|HMS3678M21|HMS3414M21|HMS3229K18|BCP05310|EX-A1069|ZINC1910234|s1066|HSCI1_000044|AKOS024456884|SB19419|CCG-206867|CS-0
Uo126,MAP2K2,380.5,C18H16N6S2,"InChI=1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+",3006531,C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N,"U0126|109511-58-2|U-0126|U 0126|1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene|UNII-8027P94HLL|CHEBI:64208|8027P94HLL|(2Z,3Z)-bis{amino[(2-aminophenyl)sulfanyl]methylidene}butanedinitrile|218601-62-8|FT-1069-1|Succinonitrile, bis(amino(o-aminophenylthio)methylene)-|Butanedinitrile, bis(amino((2-aminophenyl)thio)methylene)-|C18H16N6S2|(2z)-Bis{amino[(2-Aminophenyl)sulfanyl]methylidene}butanedinitrile|(2Z,3Z)-bis{amino[(2-aminophenyl)sulfanyl]methylene}succinonitrile|(2Z,3Z)-2,3-bis[amino-(2-"
Crenolanib,FLT3,443.5,C26H29N5O2,"InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3",10366136,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
A-83-01,TGFBR1,421.5,C25H19N5S,"InChI=1S/C25H19N5S/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18/h2-16H,1H3,(H,28,31)",16218924,CC1=CC=CC(=N1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5,"909910-43-6|A 83-01|A-83-01|A83-01|ALK5 Inhibitor IV|3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide|TGF-beta inhibitor A-83-01|1H-Pyrazole-1-carbothioamide,3-(6-methyl-2-pyridinyl)-N-phenyl-4-(4-quinolinyl)-|J-504722|C25H19N5S|Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor IV|3-(6-Methylpyridin-2-yl)-4-(4-quinolyl)-1-phenylthiocarbamoyl-1H-pyrazole|TGFss inhibitor A-83-01|SCHEMBL142081|CHEMBL1170377|KS-00001CSC|CTK8E7450|SYN5149|DTXSID60585065|EX-A482|AOB1"
KU 0063794,MTOR,465.5,C25H31N5O4,"InChI=1S/C25H31N5O4/c1-16-13-30(14-17(2)34-16)25-27-23-20(24(28-25)29-8-10-33-11-9-29)5-6-21(26-23)18-4-7-22(32-3)19(12-18)15-31/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17+",16736978,CC1CN(CC(O1)C)C2=NC3=C(C=CC(=N3)C4=CC(=C(C=C4)OC)CO)C(=N2)N5CCOCC5,"Ku-0063794|938440-64-3|KU0063794|KU-63794|UNII-81HJG228AB|KU 0063794|81HJG228AB|(5-(2-((2R,6S)-2,6-dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol|CHEMBL1078983|CHEBI:85572|(5-(2-((2S,6R)-2,6-dimethylmorpholino)-4-morpholinopyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol|rel-5-[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol|Rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morp holinyl)pyrido[2,3-d]py"
NVP-BEZ 235,MTOR,469.5,C30H23N5O,"InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3",11977753,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,"915019-65-7|NVP-BEZ235|dactolisib|BEZ235|NVP-BEZ 235|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile|BEZ-235|NVPBEZ235|BEZ 235|NVP BEZ235|BEZ235 (NVP-BEZ235)|NVP-BEZ-235|UNII-RUJ6Z9Y0DT|RUJ6Z9Y0DT|BEZ235 (NVP-BEZ235, Dactolisib)|CHEBI:71952|JOGKUKXHTYWRGZ-UHFFFAOYSA-N|2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile|2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,"
PP242,MTOR,308.32,C16H16N6O,"InChI=1S/C16H16N6O/c1-8(2)22-16-13(15(17)18-7-19-16)14(21-22)12-6-9-5-10(23)3-4-11(9)20-12/h3-8,21,23H,1-2H3,(H2,17,18,19)/b14-12-",24905147,CC(C)N1C2=C(C(=C3C=C4C=C(C=CC4=N3)O)N1)C(=NC=N2)N,PP-242| PP 242
Torin1,MTOR,607.6,C35H28F3N5O2,"InChI=1S/C35H28F3N5O2/c1-2-32(44)42-15-13-41(14-16-42)31-11-9-26(19-28(31)35(36,37)38)43-33(45)12-8-24-20-40-30-10-7-22(18-27(30)34(24)43)25-17-23-5-3-4-6-29(23)39-21-25/h3-12,17-21H,2,13-16H2,1H3",49836027,CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
BAY 61-3606,SYK,390.4,C20H18N6O3,"InChI=1S/C20H18N6O3/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19/h3-11H,1-2H3,(H2,21,27)(H,23,24,25)",10200390,COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
ER-27319,SYK,370.4,C20H22N2O5,"InChI=1S/C18H20N2O.C2H2O4/c1-12-8-9-15-17(13(12)2)20(11-5-10-19)16-7-4-3-6-14(16)18(15)21;3-1(4)2(5)6/h3-4,6-9H,5,10-11,19H2,1-2H3;(H,3,4)(H,5,6)",9799508,CC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3N2CCCN)C.C(=O)(C(=O)O)O,"ER-27319|UNII-218W96J218|218W96J218|201010-95-9|CHEMBL2170739|SCHEMBL503354|9(10H)-Acridinone, 10-(3-aminopropyl)-3,4-dimethyl-, ethanedioate (1:1)|ER-27319, &gt;=98% (HPLC), solid|10-(3-Aminopropyl)-3,4-dimethyl-9-acridone oxalate"
Piceatannol,SYK,244.24,C14H12O4,"InChI=1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+",667639,C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O,"piceatannol|10083-24-6|3-Hydroxyresveratol|astringinin|piceatanol|(E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol|3,5,3',4'-Tetrahydroxystilbene|3,3',4'5-Tetrahydroxystilbene|4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol|3,3',4,5'-Tetrahydroxystilbene|UNII-6KS3LS0D4F|NSC 365798|NSC-365798|NSC 622471|6KS3LS0D4F|CHEMBL69863|3,3',4,5'-Stilbenetetrol|4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol|CHEBI:28814|1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-|C14H12O4|NSC365798|MFCD00221715|NS"
PRT062607,SYK,393.45,C19H23N9O ,"InChI=1S/C19H23N9O/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27)/t15-,16+/m0/s1 ",,C1CC[C@H]([C@H](C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N,P505-15| PRT-062607| PRT 062607
R-406,SYK,470.5,C22H23FN6O5,"InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)",11213558,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,"841290-80-0|R-406|R406 (free base)|R406 free base|tamatinib|6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one|R406(free base)|R 406|6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one|UNII-RC3A285J2G|CHEMBL475251|RC3A285J2G|6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-2h-Pyrido[3,2-B][1,4]oxazin-3(4h)-One|AK-41797|C22H23FN6O5|BDBM50249542|6-[5-FLUORO-2"
SYK Inhibitor I,SYK,353.4,C18H15N3O3S,"InChI=1S/C18H15N3O3S/c1-21-10-11(13-4-2-3-5-17(13)21)8-15-14-9-12(25(19,23)24)6-7-16(14)20-18(15)22/h2-10H,1H3,(H,20,22)(H2,19,23,24)/b15-8-",6419747,CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC(=C4)S(=O)(=O)N)NC3=O,"Syk Inhibitor|Spleen Tyrosine Kinase Inhibitor|K00564a|CHEMBL104279|3-(1-Methyl-1H-indol-3-yl-methylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide|AC1O4WCM|GTPL6046|SCHEMBL1706133|SCHEMBL17935542|CHEBI:92522|3-(1-Methylindol-3-ylmethylene)-2-oxo-2,3-dihydroindole-5-sulfonic acid amide|HMS3229M03|BDBM50132436|HSCI1_000356|ZINC13538923|AKOS032947174|CCG-102603|RT-015833|BRD-K30189597-001-01-7|3-((1-methyl-1H-indol-3-yl)methylene)-2-oxoindoline-5-sulfonamide|(3Z)-3-[(1-methylindol-3-yl)methylidene]-2-oxo-1H-in"
SYK Inhibitor II,SYK,449.3,C14H21Cl2F3N6O3,"InChI=1S/C14H15F3N6O.2ClH.2H2O/c15-14(16,17)8-2-1-3-9(6-8)22-12-10(11(19)24)7-21-13(23-12)20-5-4-18;;;;/h1-3,6-7H,4-5,18H2,(H2,19,24)(H2,20,21,22,23);2*1H;2*1H2",16760670,C1=CC(=CC(=C1)NC2=NC(=NC=C2C(=O)N)NCCN)C(F)(F)F.O.O.Cl.Cl,"Syk Inhibitor II|227449-73-2|Syk Inhibitor II (hydrochloride)|2-(2-Aminoethylamino)-4-(3-trifluoromethylanilino)-pyrimidine-5-carboxamide, Dihydrochloride, Dihydrate|CTK8E9619|DTXSID70587914|IN1069|CCG-206793|RT-015834|J-014840|2-[(2-Aminoethyl)amino]-4-[3-(trifluoromethyl)anilino]pyrimidine-5-carboxamide--hydrogen chloride--water (1/2/2)"
SYK Inhibitor III,SYK,193.16,C9H7NO4,"InChI=1S/C9H7NO4/c11-10(12)4-3-7-1-2-8-9(5-7)14-6-13-8/h1-5H,6H2/b4-3+",672296,C1OC2=C(O1)C=C(C=C2)C=C[N+](=O)[O-],"648903-57-5|BAY-61-3606|BAY 61-3606 dihydrochloride|BAY 61-3606 (dihydrochloride)|UNII-96PPV9GQ7A|BAY 61-3606 hydrochloride|96PPV9GQ7A|CHEMBL541400|BAY-61-3606 2HCl|BAY 61-3606 2HCl|2-((7-(3,4-Dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl)amino)nicotinamide dihydrochloride|C20H18N6O3.2ClH|SCHEMBL1224258|BAY-61-3606 dihydrochloride|DTXSID20215179|BAY 61-3606(dihydrochloride)|HMS3746I13|EX-A2809|BCP24726|s7006|3472AH|AKOS027276142|CS-0234|ACN-037522|2-(7-(3,4-Dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)n"
SYK Inhibitor IV (BAY 61-3606),SYK,463.3,C20H20Cl2N6O3,"InChI=1S/C20H18N6O3.2ClH/c1-28-15-6-5-12(10-16(15)29-2)14-11-17-22-8-9-26(17)20(24-14)25-19-13(18(21)27)4-3-7-23-19;;/h3-11H,1-2H3,(H2,21,27)(H,23,24,25);2*1H",11784504,COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC.Cl.Cl,"648903-57-5|BAY-61-3606|BAY 61-3606 dihydrochloride|BAY 61-3606 (dihydrochloride)|UNII-96PPV9GQ7A|BAY 61-3606 hydrochloride|96PPV9GQ7A|CHEMBL541400|BAY-61-3606 2HCl|BAY 61-3606 2HCl|2-((7-(3,4-Dimethoxyphenyl)imidazo[1,2-c]pyrimidin-5-yl)amino)nicotinamide dihydrochloride|C20H18N6O3.2ClH|SCHEMBL1224258|BAY-61-3606 dihydrochloride|DTXSID20215179|BAY 61-3606(dihydrochloride)|HMS3746I13|EX-A2809|BCP24726|s7006|3472AH|AKOS027276142|CS-0234|ACN-037522|2-(7-(3,4-Dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)n"
PF3644022,MAPKAPK2,374.46,C21H18N4OS,,,,SHN-1668
Alsterpaullone,GSK3B,293.28,C16H11N3O3,"InChI=1S/C16H11N3O3/c20-15-8-12-11-7-9(19(21)22)5-6-14(11)18-16(12)10-3-1-2-4-13(10)17-15/h1-7,18H,8H2,(H,17,20)",5005498,C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)[N+](=O)[O-],"alsterpaullone|9-Nitropaullone|237430-03-4|NSC 705701|NSC-705701|CHEMBL50894|MLS002702475|9-Nitro-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one|9-nitro-7,12-dihydro-5H-indolo[3,2-d][1]benzazepin-6-one|9-Nitro-7,12-dihydroindolo-[3,2-d][1]benzazepin-6(5)-one|9-NITRO-5,12-DIHYDRO-7H-BENZO[2,3]AZEPINO[4,5-B]INDOL-6-ONE|Paullone Analog 1|AC1NMCUD|Kinome_3754|1q3w|Alsterpaullone derivative, 2|Lopac0_000057|CBiol_001723|GTPL5925|BDBM7262|SCHEMBL2170104|CTK8F0374|ZINC23894|BDBM84528|DTXSID50407444|CHEBI:138488|"
LiCl,GSK3B,42.4,ClLi,InChI=1S/ClH.Li/h1H;/q;+1/p-1,433294,[Li+].[Cl-],"LITHIUM CHLORIDE|7447-41-8|Lithium chloride (LiCl)|Lithiumchloride|LiCl|chlorure de lithium|Chlorku litu|chlorolithium|Lithiumchlorid|Chlorku litu [Polish]|Luthium chloride|MFCD00011078|Chlorure de lithium [French]|CCRIS 5924|UNII-G4962QA067|HSDB 4281|EINECS 231-212-3|lithium(1+) ion chloride|NSC 327172|CHEMBL69710|CHEBI:48607|NSC327172|G4962QA067|Lithium chloride, ultra dry|Lithium Chloride, Anhydrous|Lithium chloride, 99%, extra pure|ClLi|Lithium chloride, 99+%, ACS reagent|Lithium chloride, 99%, for mole"
IRAK 1-4 Inhibitor 1,IRAK1,395.4,C20H21N5O4,"InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)",11983295,C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-],IRAK-1-4 Inhibitor I|509093-47-4|IRAK-1/4 Inhibitor I|IRAK-1/4 Inhibitor|Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor|CHEMBL379787|N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide|N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole|N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitrobenzamide|IRAK-1-4InhibitorI|IRAK1/4 Inhibitor I|MLS006010636|SCHEMBL3600534|GTPL5990|CTK8E9833|DTXSID50475143|QTCFYQHZJIIHBS-UHFFFAOYSA-N|HMS3263A20|HMS3744A07|HMS3229G05|KS-00001D4X|EX-
BI 2536,PLK1,521.7,C28H39N7O3,"InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1",11364421,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,"BI 2536|755038-02-9|BI-2536|BI2536|UNII-4LJG22T9C6|4-[[(7R)-8-CYCLOPENTYL-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-6-OXO-2-PTERIDINYL]AMINO]-3-METHOXY-N-(1-METHYL-4-PIPERIDINYL)BENZAMIDE|(R)-BI-2536|CHEMBL513909|4LJG22T9C6|(R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide|4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide|C28H39N7O3|4-[[(7R)-8-cyclopentyl"
GSK461364,PLK1,543.6,C27H28F3N5O2S,"InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1",15983966,CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N,GSK461364|929095-18-1|GSK-461364|GSK 461364|5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide|GSK-461364A|(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide|UNII-8QO27TK6Q4|GSK461364A|8QO27TK6Q4|CHEMBL1908394|ZHJGWYRLJUCMRT-QGZVFWFLSA-N|SCHEMBL310080|GTPL5684|C27H28F3N5O2S|CTK8B7590|CHEBI:91333|DTXSID60239197|BCP01720|KS-00000OL5|EX-A1728|5-[6-[(4-meth
GW843682X (GSK-PLK1 Compound 2),PLK1,477.5,C22H18F3N3O4S,"InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)",9826308,COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC,"GW843682X|660868-91-7|GW 843682X|GW-843682X|GW843682|5-(5,6-dimethoxybenzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]thiophene-2-carboxamide|C22H18F3N3O4S|3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide|5-(5,6-dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide|Kinome_3462|thiophene deriv., 20|MLS006010260|BMCL191018 Compound 2|SCHEMBL1286884|CHEMBL514499|BDBM25120|CHEBI:91334|DTXSID80431373|JSKUWFIZUALZLX-UHF"
Volasertib,PLK1,618.8,C34H50N8O3,"InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1",10461508,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,"Volasertib|755038-65-4|BI 6727|BI6727 (Volasertib)|Volasertib (BI 6727)|BI-6727|UNII-6EM57086EA|BI6727|6EM57086EA|N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide|Volasertib [USAN:INN]|IBI|Volasertib (USAN)|BI6727,Volasertib|BI6727-Volasertib|Volasertib(BI6727)|BI6727 - Volasertib|Volasertib (BI6727)|BI6727 (Volasertib)/|BI 6727 (Volasertib)|MLS006011195|SCHEMBL738946|SCHEMBL9888052|SCHEMBL"
Celastrol,PRKAA2,450.6,C29H38O4,"InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26?,27+,28-,29+/m1/s1",92310323,O=C1C=C2C(=CC=C3[C@@]2(C)CCC2(C)[C@@H]4C[C@@](C)(CC[C@]4(C)CC[C@]32C)C(=O)O)C(=C1O)C,Tripterine       | Tripterin| Celastrus scandens
Compound C (Dorsomorphin),PRKAA2,399.5,C24H25N5O,"InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2",11524144,C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3,"dorsomorphin|866405-64-3|6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine|Compound C|BML-275|AMPK Inhibitor, Compound C|6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine|Dorsomorphin (Compound C)|CHEMBL478629|CHEBI:78510|MFCD08705402|4-(6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine|InSolution&amp;trade; AMPK Inhibitor, Compound C|6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine|6-[4-(2-P"
HG-9-91-01,SIK1,604.14,C32H38ClN7O3,,,,SHN-1733
PD 0332991,CDK6,483.99,C24H30ClN7O2,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",5330286,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,SHN-1106| PD0332991| PD-0332991
PD 0325901,MAP2K1,482.19,C16H14F3IN2O4,"InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1",9826528,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"391210-10-9|PD0325901|PD 0325901|PD-0325901|(R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide|PD-325901|PD 325901|(R)-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE|UNII-86K0J5AK6M|N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide|PD325901|CHEMBL507361|86K0J5AK6M|CHEBI:88249|N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide|NCGC00189075-01|N-[(2R)-2,3-dihydroxypropoxy]-3"
PD 0325901-Cl (CI-1055-R),MAP2K1,447.5,C24H29N7O2,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",5330286,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"Palbociclib|571190-30-2|PD0332991|PD-0332991|Ibrance|PD 0332991|UNII-G9ZF61LE7G|Palbociclib(PD0332991)|PD-332991|6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one|6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one|G9ZF61LE7G|PD 332991|6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE|6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-y"
PD 0325901-Cl (CI-1055-Racemic mix of isomers),MAP2K1,447.5,C24H29N7O2,"InChI=1S/C16H14ClF2IN2O4/c17-11-5-8(20)1-4-13(11)21-15-10(2-3-12(18)14(15)19)16(25)22-26-7-9(24)6-23/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m0/s1 Copy",,C1=CC(=C(C=C1I)Cl)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@H](CO)O,SHN-342| SHN342| SHN 342
PD 0325901-Cl (CI-1055-S),MAP2K1,447.5,C24H29N7O2,"InChI=1S/C16H14ClF2IN2O4/c17-11-5-8(20)1-4-13(11)21-15-10(2-3-12(18)14(15)19)16(25)22-26-7-9(24)6-23/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m0/s1 ",160968186,C1=CC(=C(C=C1I)Cl)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@H](CO)O,SHN-344| PD0325901| PD0325901-Cl | PD0325901Cl | PD 0325901Cl | PD 0325901-Cl 
PD 184352 (CI-1040),MAP2K1,478.7,C17H14ClF2IN2O2,"InChI=1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24)",6918454,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"212631-79-3|CI-1040|PD184352|PD 184352|PD-184352|2-(2-chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|PD184352 (CI-1040)|CI 1040|PD 184,352|CI1040|2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide|PD-18435|2-((2-Chloro-4-iodophenyl)amino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide|UNII-R3K9Y00J04|CHEMBL105442|R3K9Y00J04|MFCD02683961|NCGC00189074-01|C.I. 1040|CI-1040 (PD184352)|DSSTox_RID_83140|DSSTox_CID_28871|DSSTox_GSID_48945|C17H14ClF2IN2O2|2-(2-chloro-4-i"
SL-327 (MEK1-2 Inhibitor),MAP2K1,335.3,C16H12F3N3S,JLOXTZFYJNCPIS-FYWRMAATSA-N,9549284,C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F,SL327|305350-87-2|SL-327|SL 327|MEK1/2 Inhibitor|(Z)-3-amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile|MFCD06411432|Z-&amp; E-alpha-(Amino-((4-aminophenyl)thio)methylene)-2-(trifluoromethyl)benzeneacetonitrile|K00090|SCHEMBL570318|SCHEMBL570317|GTPL6008|CHEBI:92211|DTXSID90429549|AOB5954|alpha-[Amino-(4-aminophenylthio)methylene)-2-(trifluoromethyl)phenylacetonitrile|HMS3678M21|HMS3414M21|HMS3229K18|BCP05310|EX-A1069|ZINC1910234|s1066|HSCI1_000044|AKOS024456884|SB19419|CCG-206867|CS-0
Uo126,MAP2K1,380.5,C18H16N6S2,"InChI=1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+",3006531,C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N,"U0126|109511-58-2|U-0126|U 0126|1,4-Diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene|UNII-8027P94HLL|CHEBI:64208|8027P94HLL|(2Z,3Z)-bis{amino[(2-aminophenyl)sulfanyl]methylidene}butanedinitrile|218601-62-8|FT-1069-1|Succinonitrile, bis(amino(o-aminophenylthio)methylene)-|Butanedinitrile, bis(amino((2-aminophenyl)thio)methylene)-|C18H16N6S2|(2z)-Bis{amino[(2-Aminophenyl)sulfanyl]methylidene}butanedinitrile|(2Z,3Z)-bis{amino[(2-aminophenyl)sulfanyl]methylene}succinonitrile|(2Z,3Z)-2,3-bis[amino-(2-"
LFM-A13,BTK,360,C11H8Br2N2O2,"InChI=1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)/b8-6-",54676905,CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O,"lfm-a13|244240-24-2|(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide|SMR001230714|SR-01000075965|C11H8Br2N2O2|2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide|BiomolKI_000050|BiomolKI2_000056|AC1L1H0E|AC1NS4I5|Lopac0_000650|SCHEMBL51142|BSPBio_001239|BMK1-F2|MLS006010694|MLS002153290|GTPL9262|CHEBI:95065|2-cyano-N-(2,5-dibromophenyl)|HMS1362M21|HMS3678K07|HMS3414K07|HMS3403M21|HMS2235P16|HMS1990M21|HMS1792M21|BCP12817|3781AH|s7734|BS0111|ZINC37868487|AKOS024456516|CS-3890|LP00650|CCG-100654|IDI1"
PCI-32765 (Ibrutinib),BTK,440.5,C25H24N6O2,"InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1",24821094,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,"Ibrutinib|936563-96-1|PCI-32765|IMBRUVICA|Ibrutinib (PCI-32765)|PCI 32765|PCI-32765 (Ibrutinib)|UNII-1X70OSD4VX|CRA-032765|1X70OSD4VX|(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|CHEBI:76612|PCI32765|1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one|A1-01649|1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one|1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-py"
IPA-3,PAK1,350.5,C20H14O2S2,"InChI=1S/C20H14O2S2/c21-17-11-9-13-5-1-3-7-15(13)19(17)23-24-20-16-8-4-2-6-14(16)10-12-18(20)22/h1-12,21-22H",521106,C1=CC=C2C(=C1)C=CC(=C2SSC3=C(C=CC4=CC=CC=C43)O)O,"IPA-3|42521-82-4|IPA 3|1,1'-Dithiodi-2-naphthol|UNII-3XFG6MQ9G2|Bis(2-hydroxy-1-naphthyl) disulfide|3XFG6MQ9G2|1,1'-Dithiodi-2-naphthtol|CHEMBL472940|1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol|1,1'-disulfanediylbis(naphthalen-2-ol)|1-[(2-hydroxynaphthyl)disulfanyl]naphthalen-2-ol|2-Naphthol, 1,1'-dithiodi-|1,1'-disulfanediyldinaphthalen-2-ol|AC1LAV4U|IPA3|dihydroxydinaphthyldisulphide|MLS006011676|GTPL8940|SCHEMBL4907161|CHEBI:95062|CTK8G0340|DTXSID70195311|CHEBI:101355|HMS3414C17|HMS3653G03|HM"
Caffeine,ATM,194.19,C8H10N4O2,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",2519,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,"caffeine|58-08-2|1,3,7-Trimethylxanthine|Guaranine|Thein|Cafeina|Methyltheobromine|Mateina|Koffein|Theine|Alert-pep|Coffeine|Caffein|Cafipel|Refresh'n|Caffedrine|Stim|Cafamil|Caffine|Cafecon|Nodaca|Dexitac|No-Doz|Eldiatric C|7-Methyltheophylline|Organex|Hycomine|Coffein|Anhydrous caffeine|Vivarin|Nix Nap|Methyltheobromide|Coffeinum|Phensal|3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione|Caffeine, synthetic|Quick-Pep|Durvitan|Wigraine|Tirend|1,3,7-Trimethyl-2,6-dioxopurine|Theophylline, 7-methyl|DHCplus|Tri-"
KU55933,ATM,395.5,C21H17NO3S2,"InChI=1S/C21H17NO3S2/c23-14-12-16(25-20(13-14)22-8-10-24-11-9-22)15-4-3- 7-19-21(15)27-18-6-2-1-5-17(18)26-19/h1-7,12-13H,8-11H2",5278396,C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4,KU-55933| KU 55933| ATM Kinase Inhibitor
Necrostatin-1 (Nec-1),RIPK1,259.329,C13H13N3OS,"InChI=1S/C13H13N3OS/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)",2828334,CN1C(=O)C(NC1=S)CC2=CNC3=CC=CC=C32,"Necrostatin-1|4311-88-0|Necrostatin 1|MTH-DL-Tryptophan|Nec-1|5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone|MTH-trp|methyl-thiohydantoin-tryptophan|Necroptotic Inhibitor, Nec-1|5-((1H-indol-3-yl)methyl)-3-methyl-2-thioxoimidazolidin-4-one|MFCD00056916|AK326153|4-imidazolidinone, 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-|5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one|5-(indol-3-ylmethyl)-3-methyl-2-thio-Hydantoin|Methylthiohydantoin-DL-tryptophan;MTH-DL-tryptophan|5-(Indol-"
Nectrostatin-1 (Nec-1 inactive analog),RIPK1,245.3,C12H11N3OS,"InChI=1S/C12H11N3OS/c16-11-10(14-12(17)15-11)5-7-6-13-9-4-2-1-3-8(7)9/h1-4,6,10,13H,5H2,(H2,14,15,16,17)/t10-/m1/s1",5371761,c1ccc2c(c1)c(c[nH]2)C[C@@H]3C(=O)NC(=S)N3,"Necrostatin-1, Inactive Control|Nec-1i|64419-92-7|5-(Indol-3-ylmethyl)-2-thiohydantoin|MPLRRPKKFHUEEL-UHFFFAOYSA-N|5-(1H-Indol-3-ylmethyl)-2-thioxo-4-imidazolidinone|AC1NSX32|SCHEMBL838583|CHEMBL366011|CTK1I5257|DTXSID10418692|MFCD24369002|IN1206|5-(1H-indol-3-ylmethyl)-2-thiohydantoin|5-(Indole-3-yl)methyl-2-thioxo-imidazolidin-4-one|5-(1H-Indol-3-ylmethyl)-2-thioxo-imidazolidin-4-one|4-Imidazolidinone, 5-(1H-indol-3-ylmethyl)-2-thioxo-|5-(1H-Indol-3-ylmethyl)-2-thioxo-4-imidazolidinone #|5-(1H-indol-3-ylm"
Amlexanox,IKBKE,298.29,C16H14N2O4,"InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)",2161,O=C1c3cc(ccc3Oc2nc(c(cc12)C(=O)O)N)C(C)C,"amlexanox|68302-57-8|Amoxanox|Aphthasol|2-Amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid|Amlenanox|Solfa|Amlexanoxum|Amlexanoxo|Amlexanoxum [Latin]|AA-673|Amlexanoxo [Spanish]|Elics|CHX 3673|Amlexanox [USAN:INN:JAN]|AA 673|CHX-3673|UNII-BRL1C2459K|CCRIS 2686|2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid|BRN 0556384|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|BRL1C2459K|CHEBI:31205|C16H14N2O4|2-amino-5-oxo-7-propan-2-ylchrome"
CAY10576,IKBKE,469.5,C22H19N3O5S2,"InChI=1S/C22H19N3O5S2/c1-28-17-8-15-16(9-18(17)29-2)25(13-24-15)22-10-19(20(11-23)31-22)30-12-14-6-4-5-7-21(14)32(3,26)27/h4-10,13H,12H2,1-3H3",11626927,CS(C1=C(COC2=C(C#N)SC(N3C=NC4=CC(OC)=C(OC)C=C43)=C2)C=CC=C1)(=O)=O,"IKK-3 Inhibitor|862812-98-4|CAY10576|GSK319347A|IKK-3 Inhibitor IX|5-(5,6-dimethoxy-1H-1,3-benzodiazol-1-yl)-3-[(2-methanesulfonylphenyl)methoxy]thiophene-2-carbonitrile|5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarbonitrile|MLS006010828|SCHEMBL3413628|CHEMBL373751|CHEBI:91459|CTK8E9362|BDBM27452|DTXSID30469666|LDTAHRLHGHFHKP-UHFFFAOYSA-N|HMS3229F19|HMS3303L12|HMS3305M09|GSK 319347A|BCP24906|1798AH|ZINC19795634|AKOS002364333|CS-0047|NCGC00242056-02|NCGC00242056-"
OTSSP167,MELK,487.42,C25H28Cl2N4O2,"InChI=1S/C25H28Cl2N4O2/c1-14(32)18-12-28-22-9-8-21(16-10-19(26)25(33)20(27)11-16)30-24(22)23(18)29-17-6-4-15(5-7-17)13-31(2)3/h8-12,15,17,33H,4-7,13H2,1-3H3,(H,28,29)/t15-,17-",,CC(=O)c1c(c2nc(ccc2nc1)c3cc(c(c(c3)Cl)O)Cl)N[C@H]4CC[C@@H](CC4)CN(C)C,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
Novartis 12a (PKD1),PRKD1,494.51,C23H29F3N6O3,,,,SHN-1422| SHN1422| SHN 1422
"ML-7, Hydrochloride",MYLK,452.7,C15H18ClIN2O2S,"InChI=1S/C15H17IN2O2S.ClH/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19, 20)18-10-3-8-17-9-11-18;/h1-2,4-7,17H,3,8-11H2;1H",9803932,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3I.Cl,"110448-33-4|ML-7 HYDROCHLORIDE|ML-7|ML-7 HCl|1-((5-Iodonaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride|ML 7 hydrochloride|ML-7 (hydrochloride)|1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride|ML-7, Hydrochloride|MFCD00065524|AK-55561|1-(5-iodonaphthalen-1-ylsulfonyl)-1,4-diazepane hydrochloride|Hexahydro-1-[(5-iodo-1-naphthalenyl)sulfonyl]-1H-1,4-diazepine hydrochloride|1-(5-Iodonaphthalene-1-sulfonyl)homopiperazine, HCl|ML-7, powder|C15H17IN2O2S.HCl|BMK1-E6|ML-7 HYDROCHLORIDE"
"ML-9, Hydrochloride",MYLK,361.3,C15H18Cl2N2O2S,"InChI=1S/C15H17ClN2O2S.ClH/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18;/h1-2,4-7,17H,3,8-11H2;1H",108047,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl.Cl,"ML-9|105637-50-1|ML 9 hydrochloride|ML 9|UNII-BZ2L6JK93I|ML-9, Hydrochloride|1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine HCl|BZ2L6JK93I|1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride|MFCD00065525|1-(5-Chloronaphthalenesulfonyl)homopiperazine hydrochloride|1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine|1-(5-Chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride|1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl|1-(5-chloronaphthalen-1-yls"
CZC-25146,LRRK2,488.54,C22H25FN6O4S,"InChI=1S/C23H28N6O4S/c1-16-15-24-23(27-22(16)25-18-6-4-5-7-19(18)28-34(3,30)31)26-20-9-8-17(14-21(20)32-2)29-10-12-33-13-11-29/h4-9,14-15,28H,10-13H2,1-3H3,(H2,24,25,26,27)",,Cc1cnc(nc1Nc2ccccc2NS(=O)(=O)C)Nc3ccc(cc3OC)N4CCOCC4,SHN-1537| SHN1537| SHN 1537| CZC25146| CZC 25146
Genentech LRRK2 inhibitor compound 18 (GNE-7915),LRRK2,443.4,C19H21F4N5O3,,,,HG-12-92-01
Genentech LRRK2 inhibitor compound 19,LRRK2,455.41,C20H21F4N5O3,,,,HG-12-95-01 
GSK2578215A,LRRK2,399.42,C24H18FN3O2,,,,SHN-1725| GSK-2578215A| GSK 2578215A
HG-10-102-01,LRRK2,,,,,,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
LRRK2-IN1,LRRK2,570.69,C31H38N8O3,"InChI=1S/C31H38N8O3/c1-35-15-17-38(18-16-35)22-11-13-39(14-12-22)29(40)21-9-10-24(27(19-21)42-4)33-31-32-20-26-28(34-31)36(2)25-8-6-5-7-23(25)30(41)37(26)3/h5-10,19-20,22H,11-18H2,1-4H3,(H,32,33,34)",,CN1CCN(CC1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C)OCCopy,SHN-1300|  (XMD-1150)| SHN1300| SHN 1300| LRRK2IN1| LRRK2 IN1
MLi-2,LRRK2,,C21H25N5O2,"InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)",,CC1CN(CC(O1)C)c2cc(ncn2)c3c4cc(ccc4[nH]n3)OC5(CC5)C,SHN-2342
TTT-3002,LRRK2,,,,,,"856243-80-6|WP1130|Degrasyn|Degrasyn (WP1130)|WP 1130|(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acrylamide|WP-1130|CHEMBL1923233|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-2-propenamide|C19H18BrN3O|Degrasyn; WP1130|WP1130(Degrasyn)|MLS006011196|SCHEMBL882501|WP1130 - Adooq Bioscience|SCHEMBL1317674|QCR-21|DTXSID50459281|LIDOPKHSVQTSJY-VMEIHUARSA-N|AOB87145|EX-A2048|BDBM50437695|ZINC43129417|MFCD18839228|ABP000853|SB19055|CS-0483|AC-28415|SMR004702965|HY-13264|BC638857|X7509|S22"
MSC 2032964A,MAP3K5,362.31,C16H13F3N6O,"InChI=1S/C16H13F3N6O/c17-16(18,19)10-6-12(21-11-3-4-11)25-13(7-10)22-15(24-25)23-14(26)9-2-1-5-20-8-9/h1-2,5-8,11,21H,3-4H2,(H,23,24,26)",,c1cc(cnc1)C(=O)Nc2nc3cc(cc(n3n2)NC4CC4)C(F)(F)F,SHN-1391| SHN1391| SHN 1391
IRAK 1-4 Inhibitor 1,IRAK4,395.4,C20H21N5O4,"InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)",11983295,C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-],IRAK-1-4 Inhibitor I|509093-47-4|IRAK-1/4 Inhibitor I|IRAK-1/4 Inhibitor|Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor|CHEMBL379787|N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide|N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole|N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitrobenzamide|IRAK-1-4InhibitorI|IRAK1/4 Inhibitor I|MLS006010636|SCHEMBL3600534|GTPL5990|CTK8E9833|DTXSID50475143|QTCFYQHZJIIHBS-UHFFFAOYSA-N|HMS3263A20|HMS3744A07|HMS3229G05|KS-00001D4X|EX-
IRAK-4 kinase inhibitor a,IRAK4,440.45,C22H24N4O6,"InChI=1S/C22H26N4O6/c1-22(2,3)20(29)32-16-8-9-18-17(13-16)23-21(25(18)10-5-11-27)24-19(28)14-6-4-7-15(12-14)26(30)31/h4,6-9,12-13,27,30-31H,5,10-11H2,1-3H3,(H,23,24,28)",,CC(C)(C)C(=O)Oc1ccc2c(c1)nc(n2CCCO)NC(=O)c3cccc(c3)N(O)O,SHN-595a| IRAK 4| IRAK-4| IRAK4| SHN595a| SHN 595a
IRAK-4 kinase inhibitor b,IRAK4,440.45,C22H24N4O6,,,,SHN-595b
GSK2606414,EIF2AK3,451.4,C24H20F3N5O,"InChI=1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30)",53469448,CN1C=C(C2=C1N=CN=C2N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F,"GSK2606414|1337531-36-8|GSK 2606414|GSK-2606414|CHEMBL2171124|AK175551|1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone|1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone|C24H20F3N5O|1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethan-1-one|1-[5-(4-amino-7-methylpyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydroindol-1-yl]-2-[3-(trifluoromethyl)phenyl]"
MRT199665,MARK1,506.04,C28H31N5O2.ClH,"InChI=1S/C28H31N5O2.ClH/c1-28(2)22-16-29-27(30-19-8-5-7-18(15-19)17-32-13-3-4-14-32)31-25(22)33(26(28)35)23-12-11-21-20(23)9-6-10-24(21)34;/h5-10,15-16,23,34H,3-4,11-14,17H2,1-2H3,(H,29,30,31);1H",,CC1(c2cnc(nc2N(C1=O)C3CCc4c3cccc4O)Nc5cccc(c5)CN6CCCC6)C.Cl,SHN-1684
Amgen TBK 1 inhibitor (Compound II),TBK1,533.62,C28H35N7O4,"InChI=1S/C28H35N7O4/c1-33-11-13-34(14-12-33)10-5-15-39-25-17-21(16-24(37-3)26(25)38-4)31-28-29-18-20-19-30-35(27(20)32-28)22-6-8-23(36-2)9-7-22/h6-9,16-19H,5,10-15H2,1-4H3,(H,29,31,32)",,CN1CCN(CC1)CCCOc2cc(cc(c2OC)OC)Nc3ncc4cnn(c4n3)c5ccc(cc5)OC,SHN-1461| SHN1461| SHN 1461
Amlexanox,TBK1,298.29,C16H14N2O4,"InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21)",2161,O=C1c3cc(ccc3Oc2nc(c(cc12)C(=O)O)N)C(C)C,"amlexanox|68302-57-8|Amoxanox|Aphthasol|2-Amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid|Amlenanox|Solfa|Amlexanoxum|Amlexanoxo|Amlexanoxum [Latin]|AA-673|Amlexanoxo [Spanish]|Elics|CHX 3673|Amlexanox [USAN:INN:JAN]|AA 673|CHX-3673|UNII-BRL1C2459K|CCRIS 2686|2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid|BRN 0556384|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|BRL1C2459K|CHEBI:31205|C16H14N2O4|2-amino-5-oxo-7-propan-2-ylchrome"
MRT67307,TBK1,464.6,C26H36N6O2,"InChI=1S/C26H36N6O2/c33-25(21-5-2-6-21)28-11-3-10-27-24-23(20-8-9-20)17-29-26(31-24)30-22-7-1-4-19(16-22)18-32-12-14-34-15-13-32/h1,4,7,16-17,20-21H,2-3,5-6,8-15,18H2,(H,28,33)(H2,27,29,30,31)",44464263,C1CC(C1)C(=O)NCCCNC2=NC(=NC=C2C3CC3)NC4=CC=CC(=C4)CN5CCOCC5,MRT67307|1190378-57-4|MRT-67307|CHEMBL3605057|N-{3-[(5-Cyclopropyl-2-{[3-(Morpholin-4-Ylmethyl)phenyl]amino}pyrimidin-4-Yl)amino]propyl}cyclobutanecarboxamide|1FV|GTPL8062|SCHEMBL13431845|DTXSID40659192|CHEBI:124930|BCP14097|EX-A2799|BDBM50111572|3870AH|ZINC95641943|CS-0249|NCGC00378780-02|MRT 67307;MRT-67307|HY-13018|A11485|W-5811|N-[3-[[5-cyclopropyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide|N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimid
SB-431542,ALK,384.4,C22H16N4O3,"InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)",4521392,C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5,"301836-41-9|SB-431542|SB 431542|4-(4-(benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide|SB431542|UNII-E1557V1V0N|4-[4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL]BENZAMIDE|CHEMBL440084|E1557V1V0N|4-(4-(1,3-Benzodioxole-5-yl)-5-(2-pyridyl)-1H-imidazole-2-yl)benzamide|4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide|SB 431542 hydrate|C22H16N4O3|4-[4-(3,4-Methylenedioxyphenyl)-5-(2-pyridyl)-1H-imidazol-2-yl]benzamide|4-(4-Benzo[1,3]dioxol-5-yl-5-pyridin-2-yl"
SB-505124,ALK,335.3,C20H21N3O2,"InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)",9858940,WGZOTBUYUFBEPZ-UHFFFAOYSA-N,"SB-505124|694433-59-5|SB505124|SB 505124|2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine|CHEMBL226838|2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3h-imidazol-4-yl)-6-methylpyridine|2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine|2-(5-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-4-yl)-6-methylpyridine|2-[5-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-4-yl]-6-methylpyridine|2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl"
